Enanta Pharmaceuticals ENTA

$ 9.31 2.53%

Quarterly report 2024-Q2
added 08-07-2024

Enanta Pharmaceuticals EV/EBITDA Ratio 2011-2024 | ENTA

Annual EV/EBITDA Ratio Enanta Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-13.1	-20.6	28.6	14.9	32.9	13.4	4.03	40.3	20.1	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
40.3	-20.6	13.4